Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

Grand challenges in humanitarian aid.

Daar AS, Chang T, Salomon A, Singer PA.

Nature. 2018 Jul;559(7713):169-173. doi: 10.1038/d41586-018-05642-8. No abstract available.

PMID:
29993039
2.

Developmental origins of health and disease in Africa-influencing early life.

Davies JI, Macnab AJ, Byass P, Norris SA, Nyirenda M, Singhal A, Sobngwi E, Daar AS.

Lancet Glob Health. 2018 Mar;6(3):e244-e245. doi: 10.1016/S2214-109X(18)30036-6. No abstract available.

3.

The Developmental Origins of Health and Disease and Sustainable Development Goals: mapping the way forward.

Kajee N, Sobngwi E, Macnab A, Daar AS.

J Dev Orig Health Dis. 2018 Feb;9(1):5-9. doi: 10.1017/S2040174417000630. Epub 2017 Aug 14.

PMID:
28805172
4.

The World's Youngest Cadaveric Kidney Transplant: Medical, Surgical and Ethical Issues.

Daar AS, Al Lawati NM.

Transplant Direct. 2016 Nov 16;2(12):e117. eCollection 2016 Dec.

5.

Refugees in the eastern Mediterranean region.

Aljouni K, Al-Mazrou YY, Ammar WS, Daar AS, Daulaire N, Ezzati M, Fathalla M, Houssin DP, Kickbusch I, Mechbal A, Rashad HM, Sabri B.

Lancet. 2015 Dec 19;386(10012):2476-7. doi: 10.1016/S0140-6736(15)01242-8. Epub 2015 Dec 18. No abstract available.

PMID:
26738712
6.

Progress in human embryonic stem cell research in the United States between 2001 and 2010.

Vakili K, McGahan AM, Rezaie R, Mitchell W, Daar AS.

PLoS One. 2015 Mar 26;10(3):e0120052. doi: 10.1371/journal.pone.0120052. eCollection 2015.

7.

Deceased donor renal transplantation and the disruptive effect of commercial transplants: the experience of Oman.

Mohsin N, Al-Busaidy Q, Al-Marhuby H, Al-Lawati J, Daar AS.

Indian J Med Ethics. 2014 Jul-Sep;11(3):153-6.

8.

Declaration on mental health in Africa: moving to implementation.

Daar AS, Jacobs M, Wall S, Groenewald J, Eaton J, Patel V, dos Santos P, Kagee A, Gevers A, Sunkel C, Andrews G, Daniels I, Ndetei D.

Glob Health Action. 2014 Jun 13;7:24589. doi: 10.3402/gha.v7.24589. eCollection 2014.

9.

The future of replacement and restorative therapies: from organ transplantation to regenerative medicine.

Daar AS.

Transplant Proc. 2013;45(10):3450-2. doi: 10.1016/j.transproceed.2013.09.011. Review.

PMID:
24314929
10.

Grand challenges: Integrating mental health care into the non-communicable disease agenda.

Ngo VK, Rubinstein A, Ganju V, Kanellis P, Loza N, Rabadan-Diehl C, Daar AS.

PLoS Med. 2013;10(5):e1001443. doi: 10.1371/journal.pmed.1001443. Epub 2013 May 14. No abstract available.

11.

A survey of international legal instruments to examine their effectiveness in improving global health and in realizing health rights.

Wilson A, Daar AS.

J Law Med Ethics. 2013 Spring;41(1):89-102. doi: 10.1111/jlme.12007.

PMID:
23581659
12.

Innovative drugs and vaccines in China, India and Brazil.

Rezaie R, McGahan AM, Daar AS, Singer PA.

Nat Biotechnol. 2012 Oct;30(10):923-6. doi: 10.1038/nbt.2380. No abstract available.

PMID:
23051806
13.

Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators.

Rezaie R, McGahan AM, Frew SE, Daar AS, Singer PA.

Health Res Policy Syst. 2012 Jun 6;10:18. doi: 10.1186/1478-4505-10-18.

14.

The use of race, ethnicity and ancestry in human genetic research.

Ali-Khan SE, Krakowski T, Tahir R, Daar AS.

Hugo J. 2011 Dec;5(1-4):47-63. doi: 10.1007/s11568-011-9154-5. Epub 2011 Jul 7.

15.

Factors influencing agbiotech adoption and development in sub-Saharan Africa.

Ezezika OC, Daar AS, Barber K, Mabeya J, Thomas F, Deadman J, Wang D, Singer PA.

Nat Biotechnol. 2012 Jan 9;30(1):38-40. doi: 10.1038/nbt.2088. No abstract available. Erratum in: Nat Biotechnol. 2012 Feb;30(2):193.

PMID:
22231092
16.

Stakeholder involvement in expensive drug recommendation decisions: an international perspective.

Rosenberg-Yunger ZR, Thorsteinsdóttir H, Daar AS, Martin DK.

Health Policy. 2012 May;105(2-3):226-35. doi: 10.1016/j.healthpol.2011.12.002. Epub 2012 Jan 5.

PMID:
22226141
17.

Incentives for organ donation: proposed standards for an internationally acceptable system.

Working Group on Incentives for Living Donation, Matas AJ, Satel S, Munn S, Richards JR, Tan-Alora A, Ambagtsheer FJ, Asis MD, Baloloy L, Cole E, Crippin J, Cronin D, Daar AS, Eason J, Fine R, Florman S, Freeman R, Fung J, Gaertner W, Gaston R, Ghahramani N, Ghods A, Goodwin M, Gutmann T, Hakim N, Hippen B, Huilgol A, Kam I, Lamban A, Land W, Langnas A, Lesaca R, Levy G, Liquette R, Marks WH, Miller C, Ona E, Pamugas G, Paraiso A, Peters TG, Price D, Randhawa G, Reed A, Rigg K, Serrano D, Sollinger H, Sundar S, Teperman L, van Dijk G, Weimar W, Danguilan R.

Am J Transplant. 2012 Feb;12(2):306-12. doi: 10.1111/j.1600-6143.2011.03881.x. Epub 2011 Dec 17. Review.

18.

The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries.

Kapiriri L, Lavery JV, Singer PA, Mshinda H, Babiuk L, Daar AS.

BMC Public Health. 2011 Oct 18;11:811. doi: 10.1186/1471-2458-11-811.

19.

Grand challenges in global mental health.

Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS; Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health, Anderson W, Dhansay MA, Phillips A, Shurin S, Walport M, Ewart W, Savill SJ, Bordin IA, Costello EJ, Durkin M, Fairburn C, Glass RI, Hall W, Huang Y, Hyman SE, Jamison K, Kaaya S, Kapur S, Kleinman A, Ogunniyi A, Otero-Ojeda A, Poo MM, Ravindranath V, Sahakian BJ, Saxena S, Singer PA, Stein DJ.

Nature. 2011 Jul 6;475(7354):27-30. doi: 10.1038/475027a. No abstract available.

20.

Chronic Non-communicable Diseases as a Threat for All: Recent Global Initiatives.

Daar AS.

Sultan Qaboos Univ Med J. 2010 Dec;10(3):306-9. Epub 2010 Nov 14. No abstract available.

21.

Admixture mapping: from paradigms of race and ethnicity to population history.

Ali-Khan SE, Daar AS.

Hugo J. 2010 Dec;4(1-4):23-34. doi: 10.1007/s11568-010-9145-y. Epub 2010 Sep 26.

22.

Health biotechnology innovation on a global stage.

Thorsteinsdóttir H, Ray M, Kapoor A, Daar AS.

Nat Rev Microbiol. 2011 Feb;9(2):137-43. doi: 10.1038/nrmicro2492. Review.

PMID:
21233851
23.

Global health. Stagnant health technologies in Africa.

Simiyu K, Daar AS, Singer PA.

Science. 2010 Dec 10;330(6010):1483-4. doi: 10.1126/science.1195401. No abstract available.

PMID:
21148376
24.

Africa's largest long-lasting insecticide-treated net producer: lessons from A to Z Textiles.

Masum H, Shah R, Schroeder K, Daar AS, Singer PA.

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1:S6. doi: 10.1186/1472-698X-10-S1-S6.

25.

Science-based health innovation in Uganda: creative strategies for applying research to development.

Kamunyori S, Al-Bader S, Sewankambo N, Singer PA, Daar AS.

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1:S5. doi: 10.1186/1472-698X-10-S1-S5.

26.

Science-based health innovation in Tanzania: bednets and a base for invention.

Shah R, Singer PA, Daar AS.

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1:S4. doi: 10.1186/1472-698X-10-S1-S4.

27.

Science-based health innovation in Rwanda: unlocking the potential of a late bloomer.

Simiyu K, Daar AS, Hughes M, Singer PA.

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1:S3. doi: 10.1186/1472-698X-10-S1-S3.

28.

Science-based health innovation in Ghana: health entrepreneurs point the way to a new development path.

Al-Bader S, Daar AS, Singer PA.

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1:S2. doi: 10.1186/1472-698X-10-S1-S2.

29.

Venture funding for science-based African health innovation.

Masum H, Chakma J, Simiyu K, Ronoh W, Daar AS, Singer PA.

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1:S12. doi: 10.1186/1472-698X-10-S1-S12.

30.

The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan.

Perampaladas K, Masum H, Kapoor A, Shah R, Daar AS, Singer PA.

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1:S11. doi: 10.1186/1472-698X-10-S1-S11.

31.

Science-based health innovation in sub-Saharan Africa.

Al-Bader S, Masum H, Simiyu K, Daar AS, Singer PA.

BMC Int Health Hum Rights. 2010 Dec 13;10 Suppl 1:S1. doi: 10.1186/1472-698X-10-S1-S1.

32.

Regenerative medicine in Brazil: small but innovative.

McMahon DS, Singer PA, Daar AS, Thorsteinsdóttir H.

Regen Med. 2010 Nov;5(6):863-76. doi: 10.2217/rme.10.76.

33.

Priority setting for orphan drugs: an international comparison.

Rosenberg-Yunger ZR, Daar AS, Thorsteinsdóttir H, Martin DK.

Health Policy. 2011 Apr;100(1):25-34. doi: 10.1016/j.healthpol.2010.09.008. Epub 2010 Oct 18.

PMID:
20961647
34.

Innovative health service delivery models in low and middle income countries - what can we learn from the private sector?

Bhattacharyya O, Khor S, McGahan A, Dunne D, Daar AS, Singer PA.

Health Res Policy Syst. 2010 Jul 15;8:24. doi: 10.1186/1478-4505-8-24.

35.

Addressing conflicts of interest in Public Private Partnerships.

Omobowale EB, Kuziw M, Naylor MT, Daar AS, Singer PA.

BMC Int Health Hum Rights. 2010 Jul 8;10:19. doi: 10.1186/1472-698X-10-19.

36.

Intra-consortium data sharing in multi-national, multi-institutional genomic studies: gaps and guidance.

Singh JA, Daar AS.

Hugo J. 2009 Dec;3(1-4):11-4. doi: 10.1007/s11568-009-9130-5. Epub 2009 Nov 14.

37.

Shared principles of ethics for infant and young child nutrition in the developing world.

Singh JA, Daar AS, Singer PA.

BMC Public Health. 2010 Jun 8;10:321. doi: 10.1186/1471-2458-10-321.

38.

Human-animal chimeras for vaccine development: an endangered species or opportunity for the developing world?

Bhan A, Singer PA, Daar AS.

BMC Int Health Hum Rights. 2010 May 19;10:8. doi: 10.1186/1472-698X-10-8.

39.

South-South entrepreneurial collaboration in health biotech.

Thorsteinsdóttir H, Melon CC, Ray M, Chakkalackal S, Li M, Cooper JE, Chadder J, Saenz TW, Paula MC, Ke W, Li L, Madkour MA, Aly S, El-Nikhely N, Chaturvedi S, Konde V, Daar AS, Singer PA.

Nat Biotechnol. 2010 May;28(5):407-16. doi: 10.1038/nbt0510-407. No abstract available. Erratum in: Nat Biotechnol. 2010 Dec;28(12):1308.

PMID:
20458300
40.

Cultivating regenerative medicine innovation in China.

McMahon DS, Thorsteinsdóttir H, Singer PA, Daar AS.

Regen Med. 2010 Jan;5(1):35-44. doi: 10.2217/rme.09.78.

41.

Empirical bioethics research in the developing world: when the 'is' is close to an 'ought'.

Emerson CI, Upshur RE, Daar AS.

Am J Bioeth. 2009;9(6-7):101-3. doi: 10.1080/15265160902874445. No abstract available.

PMID:
19998138
42.

Globetrotting firms: Canada's health biotechnology collaborations with developing countries.

Ray M, Daar AS, Singer PA, Thorsteinsdóttir H.

Nat Biotechnol. 2009 Sep;27(9):806-14. doi: 10.1038/nbt0909-806.

PMID:
19741634
43.

The three main monotheistic religions and gm food technology: an overview of perspectives.

Omobowale EB, Singer PA, Daar AS.

BMC Int Health Hum Rights. 2009 Aug 22;9:18. doi: 10.1186/1472-698X-9-18.

44.

State of academic knowledge on toxicity and biological fate of quantum dots.

Pelley JL, Daar AS, Saner MA.

Toxicol Sci. 2009 Dec;112(2):276-96. doi: 10.1093/toxsci/kfp188. Epub 2009 Aug 14. Review.

45.

The global alliance for chronic diseases.

Daar AS, Nabel EG, Pramming SK, Anderson W, Beaudet A, Liu D, Katoch VM, Borysiewicz LK, Glass RI, Bell J.

Science. 2009 Jun 26;324(5935):1642. doi: 10.1126/science.324_1642. No abstract available.

PMID:
19556484
46.

Whole genome scanning: resolving clinical diagnosis and management amidst complex data.

Ali-Khan SE, Daar AS, Shuman C, Ray PN, Scherer SW.

Pediatr Res. 2009 Oct;66(4):357-63. doi: 10.1203/PDR.0b013e3181b0cbd8. Review.

PMID:
19531980
47.

Small but tenacious: South Africa's health biotech sector.

Al-Bader S, Frew SE, Essajee I, Liu VY, Daar AS, Singer PA.

Nat Biotechnol. 2009 May;27(5):427-45. doi: 10.1038/nbt0509-427.

PMID:
19430446
48.

Race and ancestry in biomedical research: exploring the challenges.

Caulfield T, Fullerton SM, Ali-Khan SE, Arbour L, Burchard EG, Cooper RS, Hardy BJ, Harry S, Hyde-Lay R, Kahn J, Kittles R, Koenig BA, Lee SS, Malinowski M, Ravitsky V, Sankar P, Scherer SW, Séguin B, Shickle D, Suarez-Kurtz G, Daar AS.

Genome Med. 2009 Jan 21;1(1):8. doi: 10.1186/gm8.

49.

A survey of South-North health biotech collaboration.

Melon CC, Ray M, Chakkalackal S, Li M, Cooper JE, Chadder J, Ke W, Li L, Madkour MA, Aly S, Adly N, Chaturvedi S, Konde V, Daar AS, Singer PA, Thorsteinsdóttir H.

Nat Biotechnol. 2009 Mar;27(3):229-32. doi: 10.1038/nbt0309-229. No abstract available.

PMID:
19270665
50.

TDR thirty years on: taking stock and envisioning the future for the Special Programme for Research and Training in Tropical Diseases.

Daar AS, Whyte SR, Abdullah MS, Ching-Li H, Hoffman SL, Berger M.

PLoS Negl Trop Dis. 2008;2(11):e314. doi: 10.1371/journal.pntd.0000314. Epub 2008 Nov 25. No abstract available.

Supplemental Content

Support Center